Aim Immunotech Stock Market Value
| AIM Stock | USD 0.22 0.01 4.35% |
| Symbol | AIM |
AIM ImmunoTech Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AIM ImmunoTech. If investors know AIM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AIM ImmunoTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.004 | Quarterly Revenue Growth 0.19 | Return On Assets (0.80) | Return On Equity (1.55) |
The market value of AIM ImmunoTech is measured differently than its book value, which is the value of AIM that is recorded on the company's balance sheet. Investors also form their own opinion of AIM ImmunoTech's value that differs from its market value or its book value, called intrinsic value, which is AIM ImmunoTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AIM ImmunoTech's market value can be influenced by many factors that don't directly affect AIM ImmunoTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AIM ImmunoTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if AIM ImmunoTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIM ImmunoTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AIM ImmunoTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AIM ImmunoTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AIM ImmunoTech.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in AIM ImmunoTech on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding AIM ImmunoTech or generate 0.0% return on investment in AIM ImmunoTech over 720 days. AIM ImmunoTech is related to or competes with Aptorum Group, Biocardia, Virax Biolabs, Revelation Biosciences, Kiora Pharmaceuticals, Forte Biosciences, and Cellectar Biosciences. AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple... More
AIM ImmunoTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AIM ImmunoTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AIM ImmunoTech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 34.24 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 8.33 |
AIM ImmunoTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AIM ImmunoTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AIM ImmunoTech's standard deviation. In reality, there are many statistical measures that can use AIM ImmunoTech historical prices to predict the future AIM ImmunoTech's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (1.41) | |||
| Treynor Ratio | (0.96) |
AIM ImmunoTech Backtested Returns
AIM ImmunoTech secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of return volatility over the last 3 months. AIM ImmunoTech exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AIM ImmunoTech's Coefficient Of Variation of (957.15), mean deviation of 3.61, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.57, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, AIM ImmunoTech's returns are expected to increase less than the market. However, during the bear market, the loss of holding AIM ImmunoTech is expected to be smaller as well. At this point, AIM ImmunoTech has a negative expected return of -0.58%. Please make sure to confirm AIM ImmunoTech's total risk alpha, as well as the relationship between the kurtosis and day median price , to decide if AIM ImmunoTech performance from the past will be repeated in the future.
Auto-correlation | -0.08 |
Very weak reverse predictability
AIM ImmunoTech has very weak reverse predictability. Overlapping area represents the amount of predictability between AIM ImmunoTech time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AIM ImmunoTech price movement. The serial correlation of -0.08 indicates that barely 8.0% of current AIM ImmunoTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
AIM ImmunoTech lagged returns against current returns
Autocorrelation, which is AIM ImmunoTech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AIM ImmunoTech's stock expected returns. We can calculate the autocorrelation of AIM ImmunoTech returns to help us make a trade decision. For example, suppose you find that AIM ImmunoTech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
AIM ImmunoTech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AIM ImmunoTech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AIM ImmunoTech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AIM ImmunoTech stock over time.
Current vs Lagged Prices |
| Timeline |
AIM ImmunoTech Lagged Returns
When evaluating AIM ImmunoTech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AIM ImmunoTech stock have on its future price. AIM ImmunoTech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AIM ImmunoTech autocorrelation shows the relationship between AIM ImmunoTech stock current value and its past values and can show if there is a momentum factor associated with investing in AIM ImmunoTech.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out AIM ImmunoTech Correlation, AIM ImmunoTech Volatility and AIM ImmunoTech Alpha and Beta module to complement your research on AIM ImmunoTech. To learn how to invest in AIM Stock, please use our How to Invest in AIM ImmunoTech guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
AIM ImmunoTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.